Medicalgorithmics S.A. — Board/Management Information 2024

May 22, 2024

Report Content Submissionof the Candidacy of Przemysław A. Schmidt for Member of the SupervisoryBoard of the Company and Draft Resolution on Matters Included in theAgenda of the Ordinary General Meeting of Medicalgorithmics S.A.Convened for June 12, 2024

CurrentReport No: 9/2024

Date:May 21, 2024

LegalBasis: Article 56(1)(2) of the Act on Public Offering - Current andPeriodic Information

TheManagement Board of Medicalgorithmics S.A., based in Warsaw (the_quot;Company_quot;), informs that on May 21, 2024, the Company received from itsshareholder - Biofund Capital Management LLC (_quot;BioFund_quot;), holding atleast one-twentieth of the Company's share capital:

1.Submission of a draft resolution for the Ordinary General Meeting of theCompany, convened for June 12, 2024, regarding item 16 on the agenda,i.e., changes in the composition of the Board of the Company, and

2.Nomination of Mr. Przemysław Aleksander Schmidt as a Member of theCompany Board.

1.Justification for the Request:

Theagenda of the Ordinary General Meeting includes an item regardingchanges in the composition of the_#160;Boardof the Company. The proposed draft resolution regarding the election ofa Member of the Board arises from the competences of the General Meeting(§ 17(2) of the Company's Articles of Association) and is in accordancewith the agenda introduced by the Company Management .

Theadvance nomination of Mr. Przemysław Aleksander Schmidt as a Member ofthe Board by BioFund is also in line with good market practices.

Mr.Przemysław Aleksander Schmidt is a manager, investment banker, andnon-executive member of boards of both public and private companies withover 35 years of professional experience. He holds a legal education(graduated with honors from the Faculty of Law at UAM in 1987) and haspassed both the judicial and legal advisor exams. He is also a certifiedcoach from INSEAD. BioFund is submitting the candidate's resume for the_#160;Boardalong with the draft resolution.

2.Nomination Submission:

Thesubmission includes the candidate's resume and a statement of consent tocandidacy. Additionally, the candidate has provided the Company withstatements regarding the fulfillment of the requirements for auditcommittee members specified in the Act of May 11, 2017, on StatutoryAuditors, Audit Firms, and Public Supervision, as well as on theexistence of actual and significant connections with a shareholderholding at least 5% of the total number of votes in the company, inaccordance with the requirement of rule 4.9.2 of the Best Practices ofWSE Listed Companies 2021.

Thisnomination will be considered under item 16 of the agenda of theOrdinary General Meeting convened for June 12, 2024.

Attachedto this current report, the Company provides the content of the draftresolution to be discussed at the convened Ordinary General Meeting ofthe Company, as well as the candidate's resume.

DetailedLegal Basis: § 19(1)(4) of the Regulation of the Minister of Finance ofMarch 29, 2018, on current and periodic information provided by issuersof securities and the conditions for recognizing information required bythe laws of a non-member state as equivalent.